Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sino Biopharmaceutical Limited
  6. News
  7. Summary
    1177   KYG8167W1380

SINO BIOPHARMACEUTICAL LIMITED

(1177)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sino Biopharmaceutical : Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$9.3 From HK$8.97, Keeps at Buy

03/30/2021 | 05:11am EDT


© MT Newswires 2021
All news about SINO BIOPHARMACEUTICAL LIMITED
10/18SINO BIOPHARMACEUTICAL : Biopharm's Antibiotic Wins Marketing Approval in China
MT
10/15Sino Biopharmaceutical Limited Announces Approval for the First Generic "Colistimethate..
CI
10/08SINO BIOPHARMACEUTICAL : Anti-Tumor Drug Registration Accepted in China
MT
10/08SINO BIOPHARMACEUTICAL : Gets US FDA Nod for Clinical Trial of Cough, Pain Treatment
MT
10/08Sino Biopharmaceutical Limited Announces IND Application of Innovative Medicine "Tcr167..
CI
09/13SINO BIOPHARMACEUTICAL LIMITED : Ex-dividend day for quarterly dividend
FA
09/02SINO BIOPHARMACEUTICAL : Receives Registration Approval for Cancer Treatment in China
MT
09/02SINO BIOPHARMACEUTICAL : Gets Registration Approval for Hepatitis Treatment in China
MT
09/01Hong Kong Hang Seng Rises 0.6%, Led by Tech Sector
MT
09/01Sino Biopharmaceutical Limited Announces Sofosbuvir Tablets Obtains Drug Registration C..
CI
More news
Analyst Recommendations on SINO BIOPHARMACEUTICAL LIMITED
More recommendations
Financials
Sales 2021 34 105 M 4 387 M 4 387 M
Net income 2021 10 395 M 1 337 M 1 337 M
Net cash 2021 10 880 M 1 400 M 1 400 M
P/E ratio 2021 11,8x
Yield 2021 2,25%
Capitalization 112 B 14 408 M 14 408 M
EV / Sales 2021 2,97x
EV / Sales 2022 2,38x
Nbr of Employees 24 443
Free-Float 52,2%
Chart SINO BIOPHARMACEUTICAL LIMITED
Duration : Period :
Sino Biopharmaceutical Limited Technical Analysis Chart | 1177 | KYG8167W1380 | MarketScreener
Technical analysis trends SINO BIOPHARMACEUTICAL LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 5,97 HKD
Average target price 10,57 HKD
Spread / Average Target 77,0%
EPS Revisions
Managers and Directors
Yi Li Chief Executive Officer & Executive Director
Theresa Tse Chairman
Hsuan Tse General Manager-Information Management
Wei Nong Ye General Manager-Research & Development
Mao Li Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
SINO BIOPHARMACEUTICAL LIMITED-20.40%14 624
JOHNSON & JOHNSON4.07%431 148
ROCHE HOLDING AG13.98%333 101
PFIZER, INC.14.34%239 966
NOVO NORDISK A/S56.26%238 738
ELI LILLY AND COMPANY44.35%220 952